PT847273E - Composicao farmaceutica melhorada de resina de permuta ionica - Google Patents
Composicao farmaceutica melhorada de resina de permuta ionicaInfo
- Publication number
- PT847273E PT847273E PT96928628T PT96928628T PT847273E PT 847273 E PT847273 E PT 847273E PT 96928628 T PT96928628 T PT 96928628T PT 96928628 T PT96928628 T PT 96928628T PT 847273 E PT847273 E PT 847273E
- Authority
- PT
- Portugal
- Prior art keywords
- exchange resin
- pct
- ionium
- pharmaceutical composition
- date
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9517883.6A GB9517883D0 (en) | 1995-09-01 | 1995-09-01 | Improved pharmaceutical ion exchange resin composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT847273E true PT847273E (pt) | 2002-06-28 |
Family
ID=10780065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96928628T PT847273E (pt) | 1995-09-01 | 1996-09-02 | Composicao farmaceutica melhorada de resina de permuta ionica |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6077532A (pt) |
| EP (1) | EP0847273B1 (pt) |
| AT (1) | ATE213152T1 (pt) |
| AU (1) | AU6834796A (pt) |
| DE (1) | DE69619250T2 (pt) |
| ES (1) | ES2170258T3 (pt) |
| GB (1) | GB9517883D0 (pt) |
| PT (1) | PT847273E (pt) |
| WO (1) | WO1997009036A2 (pt) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998050018A1 (en) * | 1997-05-06 | 1998-11-12 | Xiao Yu Wu | Drug delivery system |
| PL341309A1 (en) * | 1997-12-22 | 2001-04-09 | Euro Celtique | Method of preventing overdosage of opioidic preparations |
| PL193273B1 (pl) | 1997-12-22 | 2007-01-31 | Euro Celtique Sa | Postać dawkowania doustnego |
| US6221308B1 (en) * | 1999-04-20 | 2001-04-24 | Corning Incorporated | Method of making fired bodies |
| CN1423559A (zh) | 2000-02-08 | 2003-06-11 | 欧罗赛铁克股份有限公司 | 包含阿片样激动剂和拮抗剂的控释组合物 |
| PT1257277E (pt) * | 2000-02-24 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Novas combinacoes de farmacos |
| DE60238756D1 (de) | 2001-05-11 | 2011-02-10 | Endo Pharmaceuticals Inc | Opioid enthaltende arzneiform gegen missbrauch |
| US7943173B2 (en) * | 2001-07-18 | 2011-05-17 | Purdue Pharma L.P. | Pharmaceutical combinations of oxycodone and naloxone |
| WO2003013433A2 (en) | 2001-08-06 | 2003-02-20 | Euro-Celtique S.A. | Sequestered antagonist formulations |
| US20030044458A1 (en) | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| DE60232417D1 (de) | 2001-08-06 | 2009-07-02 | Euro Celtique Sa | Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist |
| US8128957B1 (en) | 2002-02-21 | 2012-03-06 | Valeant International (Barbados) Srl | Modified release compositions of at least one form of tramadol |
| US20040067216A1 (en) * | 2002-02-22 | 2004-04-08 | Karki Shyam B. | Hiv protease inhibitors supported on cation exchange resins for oral administration |
| CA2478523A1 (en) | 2002-04-05 | 2003-10-16 | Euro-Celtique S.A. | Matrix for sustained, invariant and independent release of active compounds |
| EP2422772A3 (en) | 2002-09-20 | 2012-04-18 | Alpharma, Inc. | Sequestering subunit and related compositions and methods |
| US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
| TWI347201B (en) | 2003-04-21 | 2011-08-21 | Euro Celtique Sa | Pharmaceutical products,uses thereof and methods for preparing the same |
| AU2004270188B8 (en) * | 2003-09-03 | 2010-04-29 | Mallinckrodt Inc. | Granular sustained release preparation and production thereof |
| US20050181050A1 (en) * | 2004-01-28 | 2005-08-18 | Collegium Pharmaceutical, Inc. | Dosage forms using drug-loaded ion exchange resins |
| US20070232695A1 (en) * | 2004-01-28 | 2007-10-04 | Collegium Pharmaceutical, Inc. | Gelled Periodontal Anesthetic Preparation |
| EP1604666A1 (en) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
| WO2006081518A2 (en) * | 2005-01-28 | 2006-08-03 | Collegium Pharmaceutical, Inc. | Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents |
| EP1702558A1 (en) * | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
| US8343546B2 (en) * | 2005-09-13 | 2013-01-01 | Coating Place, Inc. | Ion exchange resin treated to control swelling |
| EP1834634A3 (en) * | 2006-03-08 | 2007-10-03 | Rentschler Pharma GmbH | Pharmaceutical multiple-unit composition |
| HUE032156T2 (en) | 2006-06-19 | 2017-09-28 | Alpharma Pharmaceuticals Llc | Pharmaceutical preparations |
| WO2008105920A1 (en) * | 2007-02-28 | 2008-09-04 | Collegium Pharmaceutical, Inc. | Antihistamine combination |
| US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
| ES2706407T3 (es) | 2009-03-10 | 2019-03-28 | Euro Celtique Sa | Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona |
| AU2014295042B2 (en) | 2013-07-23 | 2017-03-30 | Mundipharma Pty Limited | A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3627583A (en) * | 1969-04-29 | 1971-12-14 | Sucrest Corp | Direct compression vehicles |
| EP0200252B1 (en) * | 1985-05-02 | 1999-03-10 | Yamanouchi Europe B.V. | Tablets comprising trimethoprim and a sulfonamide |
| EP0328877A1 (de) * | 1988-02-18 | 1989-08-23 | Oerlikon-Contraves AG | Geschoss mit Splittermantel |
| FI81004C (fi) * | 1988-02-25 | 1990-09-10 | Suomen Sokeri Oy | Binde- och utspaedningsmedel pao basis av xylitol och foerfarande foer dess framstaellning. |
| CA2002492A1 (en) * | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
| HU206975B (en) * | 1991-03-14 | 1993-03-01 | Reanal Finomvegyszergyar | Process for producing granulation and veterinary composition comprising water-soluble flumequine complex |
-
1995
- 1995-09-01 GB GBGB9517883.6A patent/GB9517883D0/en active Pending
-
1996
- 1996-09-02 DE DE69619250T patent/DE69619250T2/de not_active Expired - Lifetime
- 1996-09-02 ES ES96928628T patent/ES2170258T3/es not_active Expired - Lifetime
- 1996-09-02 AT AT96928628T patent/ATE213152T1/de active
- 1996-09-02 EP EP96928628A patent/EP0847273B1/en not_active Expired - Lifetime
- 1996-09-02 WO PCT/GB1996/002156 patent/WO1997009036A2/en active IP Right Grant
- 1996-09-02 AU AU68347/96A patent/AU6834796A/en not_active Abandoned
- 1996-09-02 PT PT96928628T patent/PT847273E/pt unknown
- 1996-09-02 US US09/029,151 patent/US6077532A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69619250D1 (de) | 2002-03-21 |
| EP0847273A2 (en) | 1998-06-17 |
| ATE213152T1 (de) | 2002-02-15 |
| WO1997009036A2 (en) | 1997-03-13 |
| ES2170258T3 (es) | 2002-08-01 |
| AU6834796A (en) | 1997-03-27 |
| DE69619250T2 (de) | 2002-08-14 |
| WO1997009036A3 (en) | 1997-04-24 |
| GB9517883D0 (en) | 1995-11-01 |
| US6077532A (en) | 2000-06-20 |
| EP0847273B1 (en) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT847273E (pt) | Composicao farmaceutica melhorada de resina de permuta ionica | |
| AU5106996A (en) | Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby | |
| BR9407239A (pt) | Azadioxacicloalquenos substituídos | |
| ES2173204T3 (es) | Formacion de particulas pequeñas. | |
| AU699480B2 (en) | 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these | |
| AU6870396A (en) | New pyrimidone derivatives with antifungal activity | |
| PT896528E (pt) | Composicoes de poliol | |
| ES2157993T3 (es) | Benzoilguanidinas, su preparacion y su uso en medicamentos. | |
| ATE259815T1 (de) | Neue antagonistische verbindungen | |
| NO973646D0 (no) | Orale doseringsformer inneholdende et <beta>-laktam antibiotikum | |
| ZA965969B (en) | Salts derived from amidine and cyclooxygenase inhibitor process for the preparation thereof their application as medicinal drugs and pharmaceutical compositions in which they are contained | |
| SI0833640T1 (en) | Pharmaceutical composition containing lamotrigine | |
| CA2104917A1 (en) | Use of Certain Anionic Surfactants to Enhance Antimicrobial Effectiveness of Ophthalmic Compositions | |
| KR950700762A (ko) | 제약학적 조성물(Pharmaceutical composition) | |
| BR9408244A (pt) | Derivados de azabiciclo[3.2.0]heptano N-substituídos | |
| AU6518496A (en) | Process for preparing optically active 1-(p-methoxybenzyl)-1,2,3,4,5,6,7,8-octahydroisoquinoline | |
| ATE234096T1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
| AU6742196A (en) | Pesticidal indazole derivatives | |
| HU9602041D0 (en) | Oral dosage form containing colestipol as a carrier and acidic substances and a process for producing the same | |
| SE9401596D0 (sv) | New compounds | |
| ES2123796T3 (es) | Derivados de acidos fosfono-succinicos y su utilizacion como medicamentos. | |
| RU94036667A (ru) | Биоэнергомодулятор | |
| JO1750B1 (en) | Substituted benzimidazole compounds, practical to prepare and use |